Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation.
about
25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future PerspectivesGuidelines for documentation and consent for nonclinical, nonresearch MRI in human subjects.Hyperintense Dentate Nuclei on T1-Weighted MRI: Relation to Repeat Gadolinium AdministrationNational Institutes of Health Perspective on Reports of Gadolinium Deposition in the Brain.Gadolinium deposition within the dentate nucleus and globus pallidus after repeated administrations of gadolinium-based contrast agents-current status.Contribution of metals to brain MR signal intensity: review articles.T1 hyperintensity on brain imaging subsequent to gadolinium-based contrast agent administration: what do we know about intracranial gadolinium deposition?The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity - A systematic review.Intraoperative resection control using arterial spin labeling - Proof of concept, reproducibility of data and initial results.T1-Weighted Hypersignal in the Deep Cerebellar Nuclei After Repeated Administrations of Gadolinium-Based Contrast Agents in Healthy Rats: Difference Between Linear and Macrocyclic Agents.Gadolinium-based contrast agents: did we miss something in the last 25 years?Distribution and clearance of retained gadolinium in the brain: differences between linear and macrocyclic gadolinium based contrast agents in a mouse model.Off-resonance magnetic resonance angiography improves visualization of in-stent lumen in peripheral nitinol stents compared to conventional T1-weighted acquisitions: an in vitro comparison study.Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.Imaging Approaches to Stroke and Neurovascular Disease.Gadolinium retention in the body: what we know and what we can do.Linear Gadolinium-Based Contrast Agents Are Associated With Brain Gadolinium Retention in Healthy Rats.Sodium MRI in Multiple Sclerosis is Compatible with Intracellular Sodium Accumulation and Inflammation-Induced Hyper-Cellularity of Acute Brain Lesions.Safety of Gadobutrol: Results From 42 Clinical Phase II to IV Studies and Postmarketing Surveillance After 29 Million ApplicationsHigh signal intensity in dentate nucleus and globus pallidus on unenhanced T1-weighted MR images in three patients with impaired renal function and vascular calcification.Pediatric Patients Demonstrate Progressive T1-Weighted Hyperintensity in the Dentate Nucleus following Multiple Doses of Gadolinium-Based Contrast Agent.Lack of increased signal intensity in the dentate nucleus after repeated administration of a macrocyclic contrast agent in multiple sclerosis: An observational study.Moderate Renal Failure Accentuates T1 Signal Enhancement in the Deep Cerebellar Nuclei of Gadodiamide-Treated Rats.The role of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: A critical update.Signal Increase on Unenhanced T1-Weighted Images in the Rat Brain After Repeated, Extended Doses of Gadolinium-Based Contrast Agents: Comparison of Linear and Macrocyclic Agents.Gadolinium-Based Contrast Agent Accumulation and Toxicity: An Update.Retention of Gadolinium-Based Contrast Agents in Multiple Sclerosis: Retrospective Analysis of an 18-Year Longitudinal Study.Repeated intravenous administration of gadobutrol does not lead to increased signal intensity on unenhanced T1-weighted images-a voxel-based whole brain analysis.The gravid uterus: MR imaging and reporting of abnormal placentation.Status and trends in the development of clinical diagnostic agents.Signal intensity change on unenhanced T1-weighted images in dentate nucleus and globus pallidus after multiple administrations of gadoxetate disodium: an intraindividual comparative study.Gadolinium based contrast agents in current practice: Risks of accumulation and toxicity in patients with normal renal function.Penetration and distribution of gadolinium-based contrast agents into the cerebrospinal fluid in healthy rats: a potential pathway of entry into the brain tissue.Exceedingly small iron oxide nanoparticles as positive MRI contrast agents.Tunable and noncytotoxic PET/SPECT-MRI multimodality imaging probes using colloidally stable ligand-free superparamagnetic iron oxide nanoparticles.Gadolinium deposition in the brain: another concern regarding gadolinium-based contrast agents.T1 Shortening in the Cerebral Cortex after Multiple Administrations of Gadolinium-based Contrast Agents.Evaluation and treatment of Langerhans cell histiocytosis patients with central nervous system abnormalities: Current views and new vistas.Biological effects of MRI contrast agents: gadolinium retention, potential mechanisms and a role for phosphorus.Deep Brain Nuclei T1 Shortening after Gadobenate Dimeglumine in Children: Influence of Radiation and Chemotherapy.
P2860
Q26774810-F778D800-7198-484F-9D8D-824FC46BFFADQ30366862-73AB7FC2-928A-43BB-BBBD-A8339F63A001Q30383185-85F3171D-82C1-4DD4-BAA2-4CB7BDA1E8D0Q31039888-95B3156C-BB69-4DB1-8D0D-317E6E634B1FQ31045014-78B2BEA2-0D61-4928-B481-5BF8899C73D3Q31051153-39E2C309-11D5-4425-8E83-CDF736518E61Q31132207-F0EB7B64-E9F6-45CA-A69B-4CA74D26C00BQ31161095-063C7F99-B638-4B4A-8AB8-147A0E186093Q33652533-EDA36B9B-6A04-4EDC-952B-20FA8A4B12AAQ35827906-32019613-4E1C-4A06-A9D5-BAFEFAB66F58Q35878856-CB99609B-176C-42F2-A8A7-1D4946984E9CQ36085936-82B44E31-1392-44C4-8615-4E1DDAED61D1Q36106277-EBEE6EAA-26D6-49EA-9F01-8FB790EDB2A5Q36316226-AD843DF4-A3E4-44B0-BFC6-C37E1314E65BQ36317835-BD6CF5DC-A47C-4A39-961A-BB2531EA5EF8Q36329191-16597EB7-0EF4-4AED-8254-7A29010A60E9Q36564222-07B28210-0FE4-4DDF-9C5D-93ED0C9B00D2Q37163249-2D9F097F-9453-47B7-8DD0-BC2B345C8EFBQ37170996-BB01CDCA-69F5-4033-AB35-3CBEEB59E2DDQ37344053-52A997F8-5F21-403F-807C-E4E2D13AC5E1Q37510442-E948D0D2-AECE-4674-927F-66E74D680A52Q37605738-07202766-049E-41DB-869C-31B1B7DB61F1Q37740128-4616455A-9D29-4666-8191-0FF2D9114B96Q38254508-55B26F8F-18D3-4E7E-A39D-75E417A9D3F6Q38327912-13EBB477-DC1F-4163-9B0C-9E5F9C6A250CQ38667169-7A7BC81B-F09D-429C-A854-92B8AC3EBF29Q38790916-28A479A4-EE14-45FF-B850-1D9F582DF57CQ38910017-7E949578-A7C2-40B5-AAB1-CEB1FD6EBA9FQ38912618-A550C061-1293-42F1-9FAB-B73DBCE011FCQ38995734-07BCCC50-917B-467B-B29A-3691E61CB00DQ40267502-50C50303-BA42-4A1C-AC5B-175ECC199C5AQ41014009-0CC6504A-C1C8-4A5C-BD4A-18CB7DBC2C08Q41029307-1303CB3B-BB14-491C-AF44-60559F8F3C86Q42318111-C340C8B7-0E56-4BAA-ADB4-306A25EBD23EQ42324167-99E71A06-3F59-4D6E-A690-29B97CF8DD8BQ42335461-BA72C1AC-5300-4DF1-9FD2-E26854D7C362Q42359366-8AF917F6-4E56-4DA0-922B-3E1877F8988AQ42515742-2D50B656-AB4A-481F-93B6-FCDFA509F510Q46158473-5164371D-6AAB-41B7-93F4-A90C2CA1F65AQ47340326-252662A9-4F03-4D16-A97F-8A08ABBE45A7
P2860
Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Progressive increase of T1 sig ...... ction, suggesting dechelation.
@en
Progressive increase of T1 sig ...... ction, suggesting dechelation.
@nl
type
label
Progressive increase of T1 sig ...... ction, suggesting dechelation.
@en
Progressive increase of T1 sig ...... ction, suggesting dechelation.
@nl
prefLabel
Progressive increase of T1 sig ...... ction, suggesting dechelation.
@en
Progressive increase of T1 sig ...... ction, suggesting dechelation.
@nl
P50
P1476
Progressive increase of T1 sig ...... ction, suggesting dechelation.
@en
P2093
Carlo Augusto Mallio
Vincenzo Cirimele
P304
P356
10.1097/RLI.0000000000000072
P577
2014-10-01T00:00:00Z